Back to search

Georgia Institute of Technology

Polyvalent vaccines and therapeutics against viral pathogens

Abstract

dc:description.abstract

Viral infections caused by HIV or influenza viruses have killed millions of people worldwide. Currently available drugs against such viruses do combat the infections to some extent but are not the best long-term solutions; drug toxicity, drug resistance and viral persistence are just some of the issues that are yet to be overcome. In this work, the concept of polyvalency was used to design viral inhibitors and vaccines. For the first part of my thesis, a universal vaccine has been developed by controlling the antigen (hemagglutinin) presentation to the immune system to enhance the accessibility of the conserved epitopes in the stalk. In preliminary in-vivo challenge experiments with a chimeric H5/1N1 virus, the hemagglutinin (head biotin)-nanotube conjugates (proposed vaccine) showed better protection than controls. We have subsequently expressed biotinylated hemagglutinin using baculoviral infection of insect cells and have optimized the purification scheme by adding a size exclusion chromatography step after the affinity chromatography step. For the second part of my thesis, polyvalent influenza therapeutics have been designed based on ‘hemagglutinin binding’ proteins that bind to conserved epitopes. We demonstrated that the dimers of both the HB proteins studied were more effective at inhibiting the binding of stalk-binding antibodies to hemagglutinin than the corresponding HB monomers. For the third part of my thesis, we designed polyvalent molecules that bind to multiple sites on HIV co-receptor, CCR5 (C-C chemokine receptor, type 5). We synthesized homodimeric, heterodimeric and multimeric versions of Leukotoxin E (LukE) (a CCR5-binding protein) and characterized their ability to inhibit the binding of a gp120-CD4 fusion protein (called FLSC) to CCR5+ 293T cells as compared to that of Leukotoxin E alone.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Chemical and Biomolecular Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rosen, Tania
Advisor dc:contributor.advisor
  • Kane, Ravi S.
Committee members dc:contributor.committeemember
  • Paravastu, Anant K.
  • Prausnitz, Mark R.
  • Platt, Manu O.
  • Roy, Krishnendu

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/58755

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Rosen, Tania. Polyvalent vaccines and therapeutics against viral pathogens. Doctoral thesis, Georgia Institute of Technology, 2017. http://hdl.handle.net/1853/58755